On- Versus Off-Label Use of Drug-Eluting Coronary Stents in Clinical Practice (Report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])
- 15 May 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (10), 1478-1481
- https://doi.org/10.1016/j.amjcard.2005.11.081
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment of saphenous vein graft lesions with drug-eluting stentsJournal of the American College of Cardiology, 2005
- Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stentsJournal of the American College of Cardiology, 2004
- Part I: identifying holes in the safety netAmerican Heart Journal, 2004
- Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarctionJournal of the American College of Cardiology, 2004
- Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”Circulation, 2004
- Sirolimus-Eluting Stent Implantation in ST-Elevation Acute Myocardial InfarctionCirculation, 2003
- TAXUS III TrialCirculation, 2003
- Sirolimus-Eluting Stent for the Treatment of In-Stent RestenosisCirculation, 2003
- The American College of Cardiology-National Cardiovascular Data Registry™ (ACC-NCDR™): building a national clinical data repositoryJournal of the American College of Cardiology, 2001
- Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collectionJournal of the American College of Cardiology, 1998